China Youzan Ltd
HKEX:8083
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
China Youzan Ltd
HKEX:8083
|
HK |
|
Immunome Inc
NASDAQ:IMNM
|
US |
|
Regis Healthcare Ltd
ASX:REG
|
AU |
|
Taiko Pharmaceutical Co Ltd
TSE:4574
|
JP |
|
S
|
Symbiox Investment & Trading Co Ltd
BSE:539278
|
IN |
|
Sanden Corp
TSE:6444
|
JP |
|
Barratt Redrow PLC
LSE:BTRW
|
UK |
|
GBM Resources Ltd
ASX:GBZ
|
AU |
|
P
|
PureWave Hydrogen Corp
XTSX:PWH
|
CA |
|
A
|
Angel Oak Mortgage REIT Inc
F:57V
|
US |
|
V
|
Voxel SA
WSE:VOX
|
PL |
|
Matsa Resources Ltd
ASX:MAT
|
AU |
|
Orix Corp
TSE:8591
|
JP |
Wall Street
Price Targets
Price Targets Summary
China Youzan Ltd
According to Wall Street analysts, the average 1-year price target for
China Youzan Ltd
is 0.107 HKD
with a low forecast of 0.051 HKD and a high forecast of 0.168 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is China Youzan Ltd's stock price target?
Price Target
0.107
HKD
According to Wall Street analysts, the average 1-year price target for
China Youzan Ltd
is 0.107 HKD
with a low forecast of 0.051 HKD and a high forecast of 0.168 HKD.
What is China Youzan Ltd's Revenue forecast?
Projected CAGR
4%
For the last 9 years the
compound annual growth rate for
China Youzan Ltd's revenue is
38%.
The projected
CAGR
for the next 3 years is
4%.
